{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T17:08:36Z","timestamp":1771348116855,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.xcrm.2025.102577","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T15:37:19Z","timestamp":1769182639000},"page":"102577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Systematic annotation of orphan RNAs reveals blood-accessible molecular barcodes of cancer identity and cancer-emergent oncogenic drivers"],"prefix":"10.1016","volume":"7","author":[{"given":"Jeffrey","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jung Min","family":"Suh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Woo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albertas","family":"Navickas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristle","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keyi","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Fish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor","family":"Cavazos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"H\u00e4nisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Markett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gillian L.","family":"Hirst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lamorna","family":"Brown-Swigart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura J.","family":"Esserman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura J.","family":"van \u2018t Veer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hani","family":"Goodarzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2025.102577_bib1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/ng0298-184","article-title":"A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma","volume":"18","author":"Knezevich","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2025.102577_bib2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0002-9343(84)90994-X","article-title":"Evidence for a 15;17 translocation in every patient with acute promyelocytic leukemia","volume":"76","author":"Larson","year":"1984","journal-title":"Am. J. Med."},{"key":"10.1016\/j.xcrm.2025.102577_bib3","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/243290a0","article-title":"Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining","volume":"243","author":"Rowley","year":"1973","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102577_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41392-022-01270-x","article-title":"Neoantigens: promising targets for cancer therapy","volume":"8","author":"Xie","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.xcrm.2025.102577_bib5","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41568-019-0162-4","article-title":"Alternative tumour-specific antigens","volume":"19","author":"Smith","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.102577_bib6","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1038\/nature21356","article-title":"Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity","volume":"543","author":"Turner","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102577_bib7","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/s41588-020-0678-2","article-title":"Extrachromosomal DNA is associated with oncogene amplification and poor outcome across multiple cancers","volume":"52","author":"Kim","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2025.102577_bib8","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1038\/s41591-018-0230-4","article-title":"Cancer cells exploit an orphan RNA to drive metastatic progression","volume":"24","author":"Fish","year":"2018","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102577_bib9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41523-024-00653-3","article-title":"Use of ctDNA in early breast cancer: analytical validity and clinical potential","volume":"10","author":"Panet","year":"2024","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.xcrm.2025.102577_bib10","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1093\/nar\/gkv808","article-title":"Large-scale profiling of microRNAs for The Cancer Genome Atlas","volume":"44","author":"Chu","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102577_bib11","doi-asserted-by":"crossref","DOI":"10.3402\/jev.v4.27493","article-title":"The NIH Extracellular RNA Communication Consortium","volume":"4","author":"Ainsztein","year":"2015","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.xcrm.2025.102577_bib12","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/s12864-017-3906-0","article-title":"A comprehensive genomic pan-cancer classification using The Cancer Genome Atlas gene expression data","volume":"18","author":"Li","year":"2017","journal-title":"BMC Genom."},{"key":"10.1016\/j.xcrm.2025.102577_bib13","article-title":"Deep Learning Based Tumor Type Classification Using Gene Expression Data","author":"Lyu","year":"2018","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2025.102577_bib14","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1038\/nm.3967","article-title":"The consensus molecular subtypes of colorectal cancer","volume":"21","author":"Guinney","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2025.102577_bib15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.cell.2018.03.022","article-title":"Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer","volume":"173","author":"Hoadley","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102577_bib16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.celrep.2018.03.063","article-title":"Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas","volume":"23","author":"Campbell","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2025.102577_bib17","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/j.ccell.2023.06.009","article-title":"Proteogenomic data and resources for pan-cancer analysis","volume":"41","author":"Li","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102577_bib18","doi-asserted-by":"crossref","DOI":"10.1126\/science.aav1898","article-title":"The chromatin accessibility landscape of primary human cancers","volume":"362","author":"Corces","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2025.102577_bib19","article-title":"Discovery of a tRNA-regulatory transcription factor that suppresses breast cancer metastasis","author":"Chen","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.xcrm.2025.102577_bib20","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/s43018-023-00554-7","article-title":"A sense-antisense RNA interaction promotes breast cancer metastasis via regulation of NQO1 expression","volume":"4","author":"Culbertson","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2025.102577_bib21","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","article-title":"Supervised risk predictor of breast cancer based on intrinsic subtypes","volume":"27","author":"Parker","year":"2009","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2025.102577_bib22","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/s41523-022-00451-9","article-title":"A perspective on the development and lack of interchangeability of the breast cancer intrinsic subtypes","volume":"8","author":"Schettini","year":"2022","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.xcrm.2025.102577_bib23","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1261\/rna.034850.112","article-title":"Potent microRNA suppression by RNA Pol II-transcribed \u2018Tough Decoy\u2019 inhibitors","volume":"19","author":"Bak","year":"2013","journal-title":"RNA"},{"key":"10.1016\/j.xcrm.2025.102577_bib24","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1093\/nar\/gkp040","article-title":"Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells","volume":"37","author":"Haraguchi","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.xcrm.2025.102577_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-41504-8","article-title":"Knockdown of Secernin 1 inhibit cell invasion and migration by activating the TGF-\u03b2\/Smad3 pathway in oral squamous cell carcinomas","volume":"13","author":"Xiao","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2025.102577_bib26","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.bbrc.2020.03.095","article-title":"PSMD12 promotes breast cancer growth via inhibiting the expression of pro-apoptotic genes","volume":"526","author":"Du","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.xcrm.2025.102577_bib27","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.molcel.2009.11.016","article-title":"Revealing Global Regulatory Perturbations across Human Cancers","volume":"36","author":"Goodarzi","year":"2009","journal-title":"Mol. Cell"},{"key":"10.1016\/j.xcrm.2025.102577_bib28","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1038\/s43018-022-00469-9","article-title":"Two isoleucyl tRNAs that decode synonymous codons divergently regulate breast cancer metastatic growth by controlling translation of proliferation-regulating genes","volume":"3","author":"Earnest-Noble","year":"2022","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.xcrm.2025.102577_bib29","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41586-021-04234-3","article-title":"MicroRNA sequence codes for small extracellular vesicle release and cellular retention","volume":"601","author":"Garcia-Martin","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2025.102577_bib30","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cell.2019.02.018","article-title":"exRNA Atlas Analysis Reveals Distinct Extracellular RNA Cargo Types and Their Carriers Present across Human Biofluids","volume":"177","author":"Murillo","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102577_bib31","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1152\/physiolgenomics.00129.2013","article-title":"5\u2019-YRNA fragments derived by processing of transcripts from specific YRNA genes and pseudogenes are abundant in human serum and plasma","volume":"45","author":"Dhahbi","year":"2013","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.xcrm.2025.102577_bib32","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1186\/1471-2164-14-298","article-title":"5\u2019 tRNA halves are present as abundant complexes in serum, concentrated in blood cells, and modulated by aging and calorie restriction","volume":"14","author":"Dhahbi","year":"2013","journal-title":"BMC Genom."},{"key":"10.1016\/j.xcrm.2025.102577_bib33","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s12609-019-00334-2","article-title":"I-SPY 2: a Neoadjuvant Adaptive Clinical Trial Designed to Improve Outcomes in High-Risk Breast Cancer","volume":"11","author":"Wang","year":"2019","journal-title":"Curr. Breast Cancer Rep."},{"key":"10.1016\/j.xcrm.2025.102577_bib34","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1080\/15476286.2018.1537746","article-title":"RNA accessibility impacts potency of Tough Decoy microRNA inhibitors","volume":"15","author":"Hooykaas","year":"2018","journal-title":"RNA Biol."},{"key":"10.1016\/j.xcrm.2025.102577_bib35","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2025.102577_bib36","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/nrc2620","article-title":"Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits","volume":"9","author":"Polyak","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.102577_bib37","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1101\/gad.1640608","article-title":"The miR-200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2","volume":"22","author":"Park","year":"2008","journal-title":"Genes Dev."},{"key":"10.1016\/j.xcrm.2025.102577_bib38","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/ncb1722","article-title":"The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1","volume":"10","author":"Gregory","year":"2008","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.xcrm.2025.102577_bib39","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41568-019-0143-7","article-title":"The broken cycle: E2F dysfunction in cancer","volume":"19","author":"Kent","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.102577_bib40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pharmthera.2018.06.008","article-title":"CDK4\/6 inhibitors in breast cancer therapy: Current practice and future opportunities","volume":"191","author":"Lynce","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.xcrm.2025.102577_bib41","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/nrc2696","article-title":"Emerging roles of E2Fs in cancer: an exit from cell cycle control","volume":"9","author":"Chen","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.102577_bib42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.annonc.2020.11.007","article-title":"Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival","volume":"32","author":"Magbanua","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.xcrm.2025.102577_bib43","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.ccell.2023.04.008","article-title":"Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy","volume":"41","author":"Magbanua","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2025.102577_bib44","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/nrc3066","article-title":"Cell-free nucleic acids as biomarkers in cancer patients","volume":"11","author":"Schwarzenbach","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.xcrm.2025.102577_bib45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13148-018-0492-1","article-title":"Circulating microRNAs as potential cancer biomarkers: the advantage and disadvantage","volume":"10","author":"Wang","year":"2018","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.xcrm.2025.102577_bib46","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1038\/s41551-023-01081-7","article-title":"Profiling of repetitive RNA sequences in the blood plasma of patients with cancer","volume":"7","author":"Reggiardo","year":"2023","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.xcrm.2025.102577_bib47","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41467-023-44461-y","article-title":"Terminal modifications independent cell-free RNA sequencing enables sensitive early cancer detection and classification","volume":"15","author":"Wang","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102577_bib48","doi-asserted-by":"crossref","first-page":"2357","DOI":"10.1038\/s41467-021-22444-1","article-title":"A comprehensive characterization of the cell-free transcriptome reveals tissue- and subtype-specific biomarkers for cancer detection","volume":"12","author":"Larson","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2025.102577_bib49","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1513750","article-title":"Adaptive Randomization of Neratinib in Early Breast Cancer","volume":"375","author":"Park","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102577_bib50","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJMoa1513749","article-title":"Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer","volume":"375","author":"Rugo","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2025.102577_bib51","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1089\/cmb.2006.13.1028","article-title":"A fast and symmetric DUST implementation to mask low-complexity DNA sequences","volume":"13","author":"Morgulis","year":"2006","journal-title":"J. Comput. Biol."},{"key":"10.1016\/j.xcrm.2025.102577_bib52","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s12859-021-04344-9","article-title":"CellProfiler 4: improvements in speed, utility and usability","volume":"22","author":"Stirling","year":"2021","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.xcrm.2025.102577_bib53","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.xcrm.2025.102577_bib54","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: A Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125006500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379125006500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T16:12:52Z","timestamp":1771344772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379125006500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":54,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2666379125006500"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102577","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic annotation of orphan RNAs reveals blood-accessible molecular barcodes of cancer identity and cancer-emergent oncogenic drivers","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2025.102577","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102577"}}